Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Fortin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 27, 2004
Prevalence and outcomes of pharmaceutical industry-sponsored clinical trials involving clozapine, risperidone, or olanzapineRic M Procyshyn, Anthony Chau, Patricia Fortin, et al.
Seminars in Pediatric Neurology|May 18, 2011
Practices and plans for knowledge translation at NeuroDevNetNazeem Muhajarine, Patricia Fortin, Fleur Macqueen Smith, et al.
American Journal of Ophthalmology Case Reports|May 23, 2022
Bell's palsy with Herpes simplex disciform keratitis: A case reportPatricia Fortin, Tyler Wickas, Henry D Perry, et al.
International Journal of Medical Informatics|August 22, 2006
Information system support as a critical success factor for chronic disease management: Necessary but not sufficientCarolyn J Green, Patricia Fortin, Malcolm Maclure, et al.
Journal of Environmental Management|May 29, 2018
Estimating the number of airports potentially contaminated with perfluoroalkyl and polyfluoroalkyl substances from aqueous film forming foam: A Canadian exampleShawn A Milley, Iris Koch, Patricia Fortin, et al.
Frontiers in Oncology|October 11, 2013
Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor ProgressionShannon Patricia Fortin Ensign, Ian T Mathews, Marc H Symons, et al.
JAMA Ophthalmology|December 13, 2019
Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control IndividualsCarol L Shields, Lauren A Dalvin, Michael Chang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 27, 2004
Prevalence and outcomes of pharmaceutical industry-sponsored clinical trials involving clozapine, risperidone, or olanzapineRic M Procyshyn, Anthony Chau, Patricia Fortin, et al.
Seminars in Pediatric Neurology|May 18, 2011
Practices and plans for knowledge translation at NeuroDevNetNazeem Muhajarine, Patricia Fortin, Fleur Macqueen Smith, et al.
American Journal of Ophthalmology Case Reports|May 23, 2022
Bell's palsy with Herpes simplex disciform keratitis: A case reportPatricia Fortin, Tyler Wickas, Henry D Perry, et al.
International Journal of Medical Informatics|August 22, 2006
Information system support as a critical success factor for chronic disease management: Necessary but not sufficientCarolyn J Green, Patricia Fortin, Malcolm Maclure, et al.
Journal of Environmental Management|May 29, 2018
Estimating the number of airports potentially contaminated with perfluoroalkyl and polyfluoroalkyl substances from aqueous film forming foam: A Canadian exampleShawn A Milley, Iris Koch, Patricia Fortin, et al.
Frontiers in Oncology|October 11, 2013
Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor ProgressionShannon Patricia Fortin Ensign, Ian T Mathews, Marc H Symons, et al.
JAMA Ophthalmology|December 13, 2019
Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control IndividualsCarol L Shields, Lauren A Dalvin, Michael Chang, et al.
Pageof 1